Sartorius Stedim Biotech's total assets for Q1 2026 were €8.19B, an increase of 2.15% from the previous quarter. FR:DIM total liabilities were €4.05B for the fiscal quarter, a 4.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.